强耀生物科技
强耀生物
强耀生物
强耀生物科技version: English | 中文版
强耀生物科技
强耀生物科技
在线客服 
强耀生物科技
强耀生物科技
微信平台
强耀生物科技
手机网站

服务
产品强耀生物科技
强耀生物
您的位置:首页>> 产品 >> 常用产品

强耀生物科技 Orphanin FQ/Nociceptin, Human, Mouse, Ox, Rat
名称 Orphanin FQ/Nociceptin, Human, Mouse, Ox, Rat
别名 Orphanin FQ,human, mouse, ox, rat
序列(单字母缩写) FGGFTGARKSARKLANQ
序列(三字母缩写) {PHE}{GLY}{GLY}{PHE}{THR}{GLY}{ALA}{ARG}{LYS}{SER}{ALA}{ARG}{LYS}{LEU}{ALA}{ASN}{GLN}
基本描述 Orphanin FQ was identified and purified from porcine brain tissue as a ligand for an orphan heterotrimeric GTP-inding protein (G protein)-coupled receptor (LC132) that is similar in sequence to opioid receptors. Orphanin FQ has a primary structure reminiscent of that of opioid peptides. Nanomolar concentrations of orphanin FQ have inhibited forskolin-stimulated adenylyl cyclase activity in cells transfected with LC132. This inhibitory activity was not affected by the addition of opioid ligands, nor did the peptide activate opioid receptors. Orphanin FQ bound to its receptor in a saturable manner and with affinity.
溶解度 The peptide is soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents.
分子量 1809.050
化学式 C79H129N27O22
纯度 > 95%
存储条件 Storage at -20°C. Keep tightly closed.
注释 In conscious rats intravenous infusion of orphanin FQ produced a profound increase in urine flow rate and decrease in urinary sodium excretion.
Documents 文档
Figures 文档
Reference Chung S, et al. Endogenous orphanin FQ / nociceptin is involved in the development of morphine tolerance. J. Pharmacol. Exp. Ther. Apr 2006.(Epub ahead of print). Marti M, et al. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J. Neursci. Oct 2005; 25(42): 9591-9601.


联系我们    |    人才招聘    |    关于我们    |    公司帐户   
联系电话:021-50795728 联系邮箱 inside@Chinapeptides.com
上海强耀生物科技有限公司 版权所有  沪ICP备16000238号